Page 2 | Certara

Press Coverage

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…

CertaraSeptember 9, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

CertaraSeptember 5, 2025

Case Study

Biogen Transforms Study Metadata Management with Certara’s Metadata Repository

Discover how study metadata management, paired with CDISC standards, transformed Biogen’s clinical trial processes and…

CertaraSeptember 5, 2025

Case Study

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Learn how Certara's project management team helped a large biotech streamline the development and updates…

CertaraSeptember 5, 2025

Blog

Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting

Stay compliant with EU rules for the pharmaceutical industry. Learn about annual safety reports and…

CertaraSeptember 5, 2025

Blog

Best Practices for Safety Narrative Writing in Clinical Research

Explore the patient narrative format in medical writing and why narrative writing in clinical research…

CertaraSeptember 5, 2025

Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

CertaraSeptember 4, 2025

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

CertaraSeptember 4, 2025

Press Release

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Pinnacle 21® Enterprise Plus delivers a 50% reduction in time spent drafting mapping specifications, according…

CertaraSeptember 4, 2025

Webinar

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

CertaraSeptember 3, 2025

© 2025 Certara. All Rights Reserved. | Legal | Privacy policy